Last quarter (Q1 2024), Revelation Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Revelation Biosciences's net income was $-2.70M. See Revelation Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20
Total Revenue	-	-	-	$ 0.00
Cost of Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Expense	$ 8.23M	$ 10.86M	$ 11.95M	$ 2.53M
Operating Income	$ -8.23M	$ -10.86M	$ -11.95M	$ -2.53M
Net Non Operating Interest Income Expense	-	-	$ -34.64K	$ 84.00
Other Income Expense	$ -7.63M	$ -34.96K	$ 36.35K	-
Pretax Income	$ -598.78K	$ -10.83M	$ -11.99M	$ -2.53M
Tax Provision	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	$ -617.35K	$ -10.83M	$ -11.99M	$ -2.53M
Basic EPS	$ -0.34	$ -20.09	$ -40.95	$ -0.20
Diluted EPS	$ -1.17	$ -20.09	$ -40.95	$ -0.20
Basic Average Shares	$ 15.41M	$ 539.04K	$ 51.99K	$ 12.94M
Diluted Average Shares	$ 16.34M	$ 539.04K	$ 51.99K	$ 12.94M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	$ 8.23M	$ 10.86M	$ 11.95M	$ 2.53M
Net Income From Continuing And Discontinued Operation	$ -617.35K	$ -10.80M	$ -11.99M	$ -2.53M
Normalized Income	$ -3.80M	-	-	$ -2.53M
Interest Expense	-	-	-	-
EBIT	$ -598.78K	$ -10.83M	$ -11.99M	$ -2.53M
EBITDA	$ -573.74K	$ -10.80M	$ 0.00	$ -2.53M

Currency in USD

Revelation Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing